GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (BOM:512529) » Definitions » Total Long-Term Liabilities

Sequent Scientific (BOM:512529) Total Long-Term Liabilities : ₹3,266 Mil (As of Mar. 2025)


View and export this data going back to 1991. Start your Free Trial

What is Sequent Scientific Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Sequent Scientific's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₹3,266 Mil.

Sequent Scientific Total Long-Term Liabilities Historical Data

The historical data trend for Sequent Scientific's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Total Long-Term Liabilities Chart

Sequent Scientific Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,562.26 1,987.46 2,211.75 2,004.35 3,265.80

Sequent Scientific Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,004.35 - 3,313.90 - 3,265.80

Sequent Scientific Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Sequent Scientific Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequent Scientific Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (BOM:512529) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:506690 BOM:530239 BOM:524348 BOM:524735 NSE:INNOVACAP BOM:524372 BOM:509079 BOM:532872 BOM:500288 NSE:RPGLIFE ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
SEQUENT:India
Address
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Website
https://www.sequent.in
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines